Large-scale testing (Phase 3)Ended earlyNCT00412217
What this trial is testing
Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer
Who this might be right for
Head and Neck Cancer
Hoffmann-La Roche 94
Showing 20 of 354 results